Skip to content
Screener

Option Care Health, Inc. OPCH Reportable Segment — Cost of Revenue

Similar metrics at other companies

BridgeBio Pharma logo
BBIOReportable Segment — Cost of Revenue
$9.94M+277%
Toast logo
TOSTReportable Segment — Cost of Revenue
$1.39B+20.6%
BAE
BAERReportable Segment — Cost of Revenue
$19.17M+2.5%
Matthews International logo
MATWReportable Segments Total — Cost of Revenue
$146.92M-31.7%
GHC
GHCReportable Segment, Aggregation before Other Operating Segment — Cost of Revenue
$674.81M+14.8%
HEICO logo
HEICorporate Segment — Cost of Revenue
$0

Other financials

Income statement

See full
Revenue$1.4B+1.9%
Gross profit$267.3M-0.7%
Operating income$85.1M+2.9%
Net income$53.9M+6.7%
EPS (diluted)$0.35+12.9%

Balance sheet

See full
Cash & equivalents$193.8M-2.5%
Total debt$1.3B+3.2%
Total equity$1.3B-7.4%
Total assets$3.4B-0.1%

Cash flow

See full
Operating cash flow$183.6M+103%
CapEx$11.1M+21.8%
Free cash flow$172.5M+112%

Valuation

See full
Market cap$3.54B-21.9%
Enterprise value$4.61B-17.0%
P/E16.9×-4.6×
P/S0.6×-0.2×

Profitability

See full
Gross margin19.1%-0.6pp
Operating margin5.9%-0.4pp
Net margin3.7%-0.2pp
FCF margin5.3%+0.8pp

Returns & leverage

See full
Return on equity16%+0.8pp
Debt / equity+0.1×
Current ratio1.5×-0.1×

Where this comes from

Reported directly by Option Care Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Option Care Health, Inc.’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:26 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001014739-26-000023
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other revenue (1)25,62323,07750,27044,868
Total Option Care Health revenue1,442,4001,416,0852,793,0542,749,057
(Expense) Income:
Cost of net revenues - drugs(1,024,241)(1,004,610)(1,973,605)(1,937,678)
Salaries, benefits, and other employee expense(213,631)(212,195)(430,224)(417,887)
Other segment items (2)(101,936)(100,329)(199,181)(199,607)
Depreciation and amortization expense(17,452)(16,241)(32,359)(31,987)
Interest expense, net(14,020)(14,447)(27,324)(27,678)

Item 1. Financial Statements

FAQ

What is Option Care Health, Inc.'s reportable segment — cost of revenue?
Option Care Health, Inc. (OPCH) reported reportable segment — cost of revenue of $1.02B in Q2 2026.
How has Option Care Health, Inc.'s reportable segment — cost of revenue changed year-over-year?
Option Care Health, Inc.'s reportable segment — cost of revenue increased by 2.0% year-over-year, from $1B to $1.02B.
What is the long-term trend for Option Care Health, Inc.'s reportable segment — cost of revenue?
Over 2 years (2023 to 2025), Option Care Health, Inc.'s reportable segment — cost of revenue has grown at a 19.0% compound annual growth rate (CAGR), from $2.81B to $3.98B.
What does reportable segment — cost of revenue mean?
This metric reflects the direct costs incurred to provide the infusion services and products sold by the reportable segment. It includes expenses directly attributable to service delivery, such as medical supplies, direct labor, and related clinical costs. Managing this metric is critical for maintaining healthy gross margins and operational efficiency within the segment.

Ask your AI about Option Care Health, Inc.'s reportable segment — cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude